Aureus Greenway Holdings Sets $4-$6 IPO Price for 3.75M Sharesby Mark Eisenberg 21.06.2024Aureus Greenway Holdings files for 3.75M share IPO at $4-$6/sh to raise funds for expansion, highlighting risks and investment considerations.
$30 Million Renovation Approved for BGSU Tech Buildingby Lilu Anderson 21.06.2024BGSU announces a $30M renovation of its technology building, modernizing facilities with updated equipment, sustainable design, and collaborative spaces.
CFTC Probes Jump Crypto Amid Legal Scrutiny and Turbulenceby John Darbie 21.06.2024CFTC investigates Jump Crypto amid a turbulent crypto landscape; scrutiny over regulatory compliance and past challenges, no comments from either ...
Micron Technology: Analysts Bullish Despite Stock Dipby Lilu Anderson 21.06.2024Micron's semiconductor fab project in Syracuse faces delays due to endangered bats and wetlands, pushing construction to 2025 despite state ...
Kroger Stock Surges After Beating Q1 Earnings Expectationsby Mark Eisenberg 20.06.2024Kroger shares rise 2.92% premarket as Q1 earnings of $1.43/share and $45.27B revenue surpass estimates, driven by strong digital growth.
ASM International: BofA Raises Target, Sees Revenue Surgeby Mark Eisenberg 20.06.2024BofA raises ASM International NV's price target to €860, citing underestimated growth and strong revenue prospects as a "critical AI ...
Honeywell Acquires CAES Systems for $1.9B in Defense Sector Boostby Mark Eisenberg 20.06.2024Honeywell to acquire CAES Systems for $1.9B to bolster its aerospace technologies amid global defense demands. Deal expected to close ...
SEC Ends Ethereum 2.0 Inquiry Following ConsenSys Lawsuitby John Darbie 20.06.2024SEC halts Ethereum 2.0 probe post ConsenSys lawsuit win; legal clarity sought for crypto growth. Ethereum spikes 5%, signaling market ...
Ethereum ETF Launch: Market Impact and Future Projectionsby John Darbie 20.06.2024Get the latest insights on Ethereum ETFs, market projections, SEC approvals, and how their launch could reshape crypto investing.
ADC Therapeutics Director Azelby Sells Shares Amid Price Target Cutby Mark Eisenberg 20.06.2024Robert Azelby sells $20,215 in ADC Therapeutics shares for tax reasons; holds 53,005 shares. Investors eye insider actions for future ...